# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Vincent van Gogh (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI010-SYN-TD
- Date: 1889-01-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elise Verhoeven, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planning. **S**

## Historical basis

- Vincent van Gogh was born on March 30, 1853, and decided to become an artist at the age of 27. **D**
- In October 1888 the painter Paul Gauguin joined Van Gogh at the Yellow House in Arles, in the south of France, where Van Gogh hoped to found an artists' community; their discussions about art became more frequent and heated, and the situation deteriorated. **D**
- On December 23, 1888, when he was 35, after a heated argument, Van Gogh cut off his left ear in a state of utter confusion. The police found him at home the next morning and took him to hospital. He could later recall nothing of what had happened. **D**
- In the hospital in Arles he was treated by the assistant physician Dr. Felix Rey. His condition worsened and he spent several days in isolation; he then recovered slowly and went home after about two weeks, on January 7, 1889. **D**
- He drank heavily in Paris from 1886, probably both absinthe and wine, and later wrote to his brother that he had become almost an alcoholic from overdoing it; in Arles he seems to have cut down. **D**
- Nolen and colleagues judged that he had an alcohol use disorder, with dependence shown by failed attempts to cut down in Arles, made worse by malnutrition and poor sleep. **R**
- Nolen and colleagues concluded that he probably had a bipolar mood disorder, more likely bipolar II than bipolar I, with recurrent depressive episodes, some of them psychotic, and probably hypomanic symptoms. The Van Gogh Museum states that no all-embracing diagnosis has been found. **R**
- Nolen and colleagues also found strong indications of borderline personality traits, present as an underlying vulnerability from young adulthood. **R**
- Nolen and colleagues proposed that the brief psychosis after the ear incident was a delirium from alcohol withdrawal, because he was forced to stop drinking suddenly when he was admitted to hospital. The writer Martin Bailey questioned part of their reasoning, arguing that they underestimated how much he went on drinking afterwards. **R**
- Nolen and colleagues concluded that focal (temporal lobe) epilepsy, which Dr. Rey had suggested in Arles, cannot be excluded as an additional condition, although its probability cannot be judged without an EEG or brain imaging. **R**
- Schizophrenia, Meniere's disease, syphilis, acute intermittent porphyria and thujone poisoning from absinthe have also been proposed; Nolen and colleagues judged schizophrenia and the others unlikely or highly unlikely, because he had no psychotic symptoms between episodes and no negative symptoms. **R**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He wants to understand what happened to him and to stop it happening again, and is frightened that it will. **S**
- He wants to paint every day again and to be able to concentrate. **S**
- He is worried about his drinking and his sleep. **S**

## Strengths and supports

- Supports: a friend he paints with who lives nearby, and the coordinated specialty care team; his work is his strongest reason to get well. He decides who is told about his health **S**

## Medications and allergies

- Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital) **S**
- Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital) **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1886: Heavy drinking, probably both absinthe and wine, from his time in Paris **D** (CLM-0009)
- December 23, 1888: First crisis, with confusion and an injury to his left ear; hospital care in Arles with several days in isolation; went home after about two weeks **D** (CLM-0003, CLM-0004)

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

White cells: 6.8 10*3/uL; Hemoglobin: 14.2 g/dL; MCV: 102 fL (high); Platelets: 172 10*3/uL; Sodium: 137 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.94 mg/dL; eGFR: 108 mL/min/1.73 m²; Fasting glucose: 91 mg/dL; Hemoglobin A1c: 5.3%; Total cholesterol: 184 mg/dL; LDL cholesterol: 106 mg/dL; HDL cholesterol: 52 mg/dL; Triglycerides: 130 mg/dL; AST: 58 U/L (high); ALT: 44 U/L; GGT: 96 U/L (high); TSH: 1.8 mIU/L; Vitamin B12: 388 pg/mL; Phosphatidylethanol (PEth): 284 ng/mL (high); PHQ-9: 13; AUDIT-C: 9. All results are synthetic.

BP 128/80 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 64 kg; BMI 22.1 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert and oriented; quiet and cooperative; speech normal in rate; no current hallucinations by report, though he sometimes hears his name called as he falls asleep; mild suspiciousness at night; thought process organized; insight growing; Mood low and flat, ashamed of the episode, which he cannot remember well; PHQ-9 score 13 with item 9 scored 1 for passive thoughts that it would be easier not to wake up; no intent, plan or preparation; no thoughts of harming others. Functional status: Independent in all activities; not yet painting since discharge because he cannot concentrate for long; manages his money and medicines. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: present; intent: absent; plan: absent; access reviewed: yes. Disposition: Outpatient care with close follow-up. He has passive thoughts that it would be easier not to wake up, without intent, plan or preparation; the self-injury during the episode happened in confusion and without suicidal intent. His risk is higher in the months after a first episode of psychosis, while he is depressed, and while he is drinking. A written safety plan was made with him, with his own early warning signs (nights with little sleep, hearing voices, drinking more, pulling away from his friend) and what to do about each. Lethal-means counseling: he has no firearm and no access to one and agreed not to acquire one; medicines are dispensed two weeks at a time; he will keep alcohol out of the house while he is low. The 988 Suicide & Crisis Lifeline was given and saved in his phone, with the clinic number. Safety reviewed at every visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisis; status draft. **S**
2. Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinking; status draft. **S**
3. Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospital; status draft. **S**

## Plan

- Continue the antipsychotic started in hospital at the lowest effective dose, with side-effect checks at each visit (akathisia, stiffness, sedation) and monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose, A1c and lipids at baseline, 12 weeks and yearly, and the AIMS at baseline and every six months. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Psychiatry consultation with the first-episode psychosis coordinated specialty care team to review the provisional diagnosis and differential, the dose, the alcohol plan, and the workup for epilepsy. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- First-episode workup: blood count, metabolic panel, liver tests, thyroid test, vitamin B12, HIV and syphilis tests, urine drug test, brain MRI, and a sleep-deprived EEG because of the confusion and the question of seizures. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**
- Alcohol care: AUDIT-C, PEth at each check to follow drinking, brief counseling with goals he chooses, thiamine, and a medicine for alcohol use disorder once the liver tests are reviewed. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Coordinated specialty care: a care coordinator, individual resilience-focused therapy, education about psychosis for him and for the people he chooses, support to return to painting and selling his work, and a peer specialist. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- Sleep as treatment and as an early warning sign: regular sleep and wake times, no alcohol to get to sleep, less coffee after noon, and a plan to call the team after two nights of short sleep. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) **S**
- Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, PHQ-9 at each visit, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020), American Psychiatric Association (American Journal of Psychiatry)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018), CANMAT and ISBD (Bipolar Disorders)
- The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence (2023), Focus (American Psychiatric Publishing)
- Consensus development conference on antipsychotic drugs and obesity and diabetes (2004), American Diabetes Association, American Psychiatric Association, AACE, and NAASO (Diabetes Care)
- Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026), National Institute of Mental Health
- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
